Log In
BCIQ
Print this Print this
 

T3914

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
DescriptionNSAID
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today